Topical acidic cream prevents the development of atopic dermatitis- and asthma-like lesions in murine model

Hae Jin Lee, Na Young Yoon, Noo Ri Lee, Minyoung Jung, Dong Hye Kim, Eung Ho Choi

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Long-standing or repeated skin barrier damage followed by atopic dermatitis (AD) is the initial step of the atopic march that eventually progresses to respiratory allergies. Maintenance of an acidic pH in the stratum corneum (SC) is an important factor for normal skin barrier function. We performed this study to determine whether an oxazolone (Ox)-induced AD murine model can develop airway inflammation by topical application and nasal inhalation of a house dust mite, Dermatofagoides pteronyssinus (Dp), which is a novel 'atopic march animal model', and whether an acidic SC environment, made by repeated application of acidic cream, can interrupt this atopic march. During repeated treatment with Ox and Dp to make an atopic march murine model, acidic cream (pH 2.8) and neutral cream (pH 7.4) adjusted by citric acid and sodium hydroxide mixed with vehicle were applied twice daily. Repeated treatment with Ox and Dp to hairless mice induced AD-like skin lesions followed by respiratory allergy, defining it as an atopic march model. Acidic cream inhibited the occurrence of respiratory allergic inflammation as well as AD-like skin lesions. These results indicate that a novel atopic march animal model can be developed by repeated topical and nasal treatments with house dust mite on Ox-induced AD mice and that the acidification of SC could be a novel intervention method to block the atopic march.

Original languageEnglish
Pages (from-to)736-741
Number of pages6
JournalExperimental dermatology
Volume23
Issue number10
DOIs
Publication statusPublished - 2014 Oct 1

Fingerprint

Oxazolone
Atopic Dermatitis
Asthma
Skin
Cornea
Allergies
Pyroglyphidae
Nose
Dust
Hypersensitivity
Animals
Animal Models
Inflammation
Hairless Mouse
Sodium Hydroxide
Acidification
Citric Acid
Inhalation
Maintenance

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Biology
  • Dermatology

Cite this

Lee, Hae Jin ; Yoon, Na Young ; Lee, Noo Ri ; Jung, Minyoung ; Kim, Dong Hye ; Choi, Eung Ho. / Topical acidic cream prevents the development of atopic dermatitis- and asthma-like lesions in murine model. In: Experimental dermatology. 2014 ; Vol. 23, No. 10. pp. 736-741.
@article{cde454a6cc9448a0af84d7f34a8412d0,
title = "Topical acidic cream prevents the development of atopic dermatitis- and asthma-like lesions in murine model",
abstract = "Long-standing or repeated skin barrier damage followed by atopic dermatitis (AD) is the initial step of the atopic march that eventually progresses to respiratory allergies. Maintenance of an acidic pH in the stratum corneum (SC) is an important factor for normal skin barrier function. We performed this study to determine whether an oxazolone (Ox)-induced AD murine model can develop airway inflammation by topical application and nasal inhalation of a house dust mite, Dermatofagoides pteronyssinus (Dp), which is a novel 'atopic march animal model', and whether an acidic SC environment, made by repeated application of acidic cream, can interrupt this atopic march. During repeated treatment with Ox and Dp to make an atopic march murine model, acidic cream (pH 2.8) and neutral cream (pH 7.4) adjusted by citric acid and sodium hydroxide mixed with vehicle were applied twice daily. Repeated treatment with Ox and Dp to hairless mice induced AD-like skin lesions followed by respiratory allergy, defining it as an atopic march model. Acidic cream inhibited the occurrence of respiratory allergic inflammation as well as AD-like skin lesions. These results indicate that a novel atopic march animal model can be developed by repeated topical and nasal treatments with house dust mite on Ox-induced AD mice and that the acidification of SC could be a novel intervention method to block the atopic march.",
author = "Lee, {Hae Jin} and Yoon, {Na Young} and Lee, {Noo Ri} and Minyoung Jung and Kim, {Dong Hye} and Choi, {Eung Ho}",
year = "2014",
month = "10",
day = "1",
doi = "10.1111/exd.12525",
language = "English",
volume = "23",
pages = "736--741",
journal = "Experimental Dermatology",
issn = "0906-6705",
publisher = "Wiley-Blackwell",
number = "10",

}

Topical acidic cream prevents the development of atopic dermatitis- and asthma-like lesions in murine model. / Lee, Hae Jin; Yoon, Na Young; Lee, Noo Ri; Jung, Minyoung; Kim, Dong Hye; Choi, Eung Ho.

In: Experimental dermatology, Vol. 23, No. 10, 01.10.2014, p. 736-741.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Topical acidic cream prevents the development of atopic dermatitis- and asthma-like lesions in murine model

AU - Lee, Hae Jin

AU - Yoon, Na Young

AU - Lee, Noo Ri

AU - Jung, Minyoung

AU - Kim, Dong Hye

AU - Choi, Eung Ho

PY - 2014/10/1

Y1 - 2014/10/1

N2 - Long-standing or repeated skin barrier damage followed by atopic dermatitis (AD) is the initial step of the atopic march that eventually progresses to respiratory allergies. Maintenance of an acidic pH in the stratum corneum (SC) is an important factor for normal skin barrier function. We performed this study to determine whether an oxazolone (Ox)-induced AD murine model can develop airway inflammation by topical application and nasal inhalation of a house dust mite, Dermatofagoides pteronyssinus (Dp), which is a novel 'atopic march animal model', and whether an acidic SC environment, made by repeated application of acidic cream, can interrupt this atopic march. During repeated treatment with Ox and Dp to make an atopic march murine model, acidic cream (pH 2.8) and neutral cream (pH 7.4) adjusted by citric acid and sodium hydroxide mixed with vehicle were applied twice daily. Repeated treatment with Ox and Dp to hairless mice induced AD-like skin lesions followed by respiratory allergy, defining it as an atopic march model. Acidic cream inhibited the occurrence of respiratory allergic inflammation as well as AD-like skin lesions. These results indicate that a novel atopic march animal model can be developed by repeated topical and nasal treatments with house dust mite on Ox-induced AD mice and that the acidification of SC could be a novel intervention method to block the atopic march.

AB - Long-standing or repeated skin barrier damage followed by atopic dermatitis (AD) is the initial step of the atopic march that eventually progresses to respiratory allergies. Maintenance of an acidic pH in the stratum corneum (SC) is an important factor for normal skin barrier function. We performed this study to determine whether an oxazolone (Ox)-induced AD murine model can develop airway inflammation by topical application and nasal inhalation of a house dust mite, Dermatofagoides pteronyssinus (Dp), which is a novel 'atopic march animal model', and whether an acidic SC environment, made by repeated application of acidic cream, can interrupt this atopic march. During repeated treatment with Ox and Dp to make an atopic march murine model, acidic cream (pH 2.8) and neutral cream (pH 7.4) adjusted by citric acid and sodium hydroxide mixed with vehicle were applied twice daily. Repeated treatment with Ox and Dp to hairless mice induced AD-like skin lesions followed by respiratory allergy, defining it as an atopic march model. Acidic cream inhibited the occurrence of respiratory allergic inflammation as well as AD-like skin lesions. These results indicate that a novel atopic march animal model can be developed by repeated topical and nasal treatments with house dust mite on Ox-induced AD mice and that the acidification of SC could be a novel intervention method to block the atopic march.

UR - http://www.scopus.com/inward/record.url?scp=84907853766&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907853766&partnerID=8YFLogxK

U2 - 10.1111/exd.12525

DO - 10.1111/exd.12525

M3 - Article

C2 - 25078153

AN - SCOPUS:84907853766

VL - 23

SP - 736

EP - 741

JO - Experimental Dermatology

JF - Experimental Dermatology

SN - 0906-6705

IS - 10

ER -